#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypersensitivity pneumonitis Peritoneal neoplasm Short-bowel syndrome Heritable pulmonary arterial hypertension Chronic lymphocytic leukaemia Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Mucopolysaccharidosis II Diffuse large B-cell lymphoma Craniocerebral injury Barth syndrome Liposarcoma Mixed-type liposarcoma Mantle cell lymphoma stage III Craniopharyngioma Mantle cell lymphoma More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Basic Information Amyotrophic lateral sclerosis – Treatment Haemophilia B without inhibitors – Diagnostics Wolfram syndrome MELAS syndrome – Basic Information Inclusion body myositis – Treatment Retinoblastoma – Treatment Ocular melanoma – Life with Disease Inclusion body myositis – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avacincaptad Pegol Air, Medicinal Dexmedetomidine Hydrochloride Eptacog Alfa (Activated) Irbesartan Cefuroxime Sodium Omp10 Charcoal, Activated Vesleteplirsen TIL CELLS Cisatracurium Besilate Human Coagulation Factor Ii Quizartinib Dihydrochloride Lysine Hydrochloride PEGZILARGINASE Maraviroc Potassium Oxybate Microcrystalline Cellulose Ammonium Chloride Bp Vonafexor More therapies…

    Learn about Your Condition

    Supranuclear palsy Subdural haematoma Coronary artery bypass Nicotine dependence Androgenetic alopecia Delayed graft function Osteosarcoma recurrent Muscle strain Optic glioma Follicular lymphoma stage II Cerebral haemorrhage Postoperative delirium Mechanical ventilation Systemic infection Cholangiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer…

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

54 Rue Henri Sainte Claire Deville, Toulon, 83100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Safety and efficacy of stopping versus maintenance dose of filgotinib, tofacitinib and upadacitinib in adult ulcerative colitis patients in deep remission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Tofacitinib
    • Filgotinib
    • Upadacitinib
    France

  • Effect of Acetazolamide Added to Standard Therapy on Weight Reduction and Symptom Relief in Patients with Heart Failure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Acetazolamide
    France

  • Morning Versus Afternoon Pembrolizumab, Carboplatin, and Pemetrexed in Adults With Stage IV Non-Squamous Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Pembrolizumab
    • Pemetrexed Disodium
    France

  • Study of dexmedetomidine and a drug combination for treating patients on mechanical ventilation with septic shock.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Dexmedetomidine
    • Noradrenaline Tartrate
    France

  • A study comparing vedolizumab, filgotinib, ustekinumab, and infliximab to maintain remission in patients with ulcerative colitis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ustekinumab
    • Filgotinib
    • Infliximab
    France

  • Using a drug combination to treat vaginal flora abnormalities in pregnant women at high risk of preterm birth.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Azithromycin Dihydrate
    • Ceftriaxone
    • Clotrimazole
    France

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia France Germany Greece Poland +1

  • Study of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Ivonescimab
    France

  • Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9
Previous Page
1 2 3 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!